Comparison between brain natriuretic peptide and calcitonin gene-related peptide in children with dilated

Noor Mohammad Noori1, Alireza Teimouri1, Iraj Shahramian2

  • 1Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

Insights

In children with dilated cardiomyopathy (DCM), both calcitonin gene-related peptide (CGRP) and brain natriuretic peptide (BNP) levels were elevated compared to controls. BNP showed a stronger correlation with disease severity, suggesting it may be a more effective biomarker for DCM in pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Biomarker Discovery
  • Cardiovascular Research

Background:

  • Dilated cardiomyopathy (DCM) is characterized by left ventricular enlargement and impaired systolic function.
  • Understanding biomarkers for pediatric DCM is crucial for diagnosis and management.

Purpose of the Study:

  • To compare levels of calcitonin gene-related peptide (CGRP) and brain natriuretic peptide (BNP) in children with DCM versus healthy controls.
  • To evaluate the correlation of CGRP and BNP with disease severity in pediatric DCM.

Main Methods:

  • Biomarker levels (BNP, CGRP) were measured using ELISA in pediatric DCM patients and controls.
  • Echocardiographic findings were assessed and compared between groups.
  • Correlation between biomarker levels and the Ross classification of disease severity was analyzed.

Main Results:

  • Children with DCM exhibited significantly higher mean levels of both BNP and CGRP compared to controls (P < 0.001 for BNP, P = 0.001 for CGRP).
  • Echocardiographic parameters differed significantly between DCM patients and controls (P < 0.05).
  • BNP levels demonstrated a significant positive correlation with the Ross classification of disease severity (P < 0.05), while CGRP did not.

Conclusions:

  • Elevated BNP and CGRP levels are observed in children with DCM.
  • BNP appears to be a more reliable biomarker for assessing disease severity in pediatric DCM than CGRP.
  • BNP may serve as a valuable clinical tool for managing pediatric DCM.
Abstract